Showing results (21-30 of 88) with videos related to

Sort By:
Pageof 9
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
Bis-sulfonamides as endothelin receptor antagonistsChristoph Boss, Martin H Bolli, Thomas Weller, et al.
Journal of Chemical Information and Modeling|January 19, 2012
Fighting high molecular weight in bioactive molecules with sub-pharmacophore-based virtual screeningModest von Korff, Joel Freyss, Thomas Sander, et al.
Epilepsia|April 1, 2025
Antiseizure potential of the triple T-type calcium channel blocker ACT-709478 (apinocaltamide) in rodent modelsMelanie Kessler, Hélène Roellinger, Corinne Roucard, et al.
Bioorganic & Medicinal Chemistry Letters|March 6, 2003
The use of sulfonylamido pyrimidines incorporating an unsaturated side chain as endothelin receptor antagonistsMartin H Bolli, Christoph Boss, Martine Clozel, et al.
Archives of Ophthalmology (Chicago, Ill. : 1960)|February 13, 2008
Ametropia, preschoolers' cognitive abilities, and effects of spectacle correctionAnne-Catherine Roch-Levecq, Barbara L Brody, Ronald G Thomas, et al.
Inorganic Chemistry|February 18, 2022
Improvement of the Hydrolytic Stability of the Keggin Molybdo- and Tungsto-Phosphate Anions by CyclodextrinsSa Yao, Clément Falaise, Nathalie Leclerc, et al.
Ophthalmic Epidemiology|September 27, 2007
Refractive errors in low-income preschoolersBarbara L Brody, Anne-Catherine Roch-Levecq, Hillary S Klonoff-Cohen, et al.
Magnetic Resonance in Chemistry : MRC|April 25, 2017
High-field 95 Mo and 183 W static and MAS NMR study of polyoxometalatesMohamed Haouas, Julien Trébosc, Catherine Roch-Marchal, et al.
Chemmedchem|April 17, 2013
Discovery and characterization of ACT-335827, an orally available, brain penetrant orexin receptor type 1 selective antagonistMichel A Steiner, John Gatfield, Catherine Brisbare-Roch, et al.
Pageof 9